Description
Rofuclav 500 mg Tablet is a combination antibiotic medication manufactured by Radiant Pharmaceuticals Ltd., designed to treat a wide range of bacterial infections. It contains two active ingredients:
-
Cefuroxime (500 mg): A second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death.
-
Clavulanic Acid (125 mg): A beta-lactamase inhibitor that protects cefuroxime from degradation by beta-lactamase-producing bacteria, thereby enhancing its efficacy.
This combination is effective against various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, gonorrhea, Lyme disease, septicemia, and meningitis. It is also used in switch therapy from injectable to oral administration. The dosage and duration of treatment depend on the specific infection and patient factors. Common side effects may include nausea, diarrhea, and rash. It is important to complete the full course of treatment as prescribed to prevent the development of antibiotic-resistant bacteria.
 ..jpeg)
 2GM.jpeg)
 1GM.jpeg)
60 MG.jpeg)
 20MG.jpeg)
 ..jpeg)
 10MG.jpeg)
 25MG.jpeg)
.jpeg)
Change Language